Skip to main content
TEYI PHARMACEUTICAL GROUP CO.,LTD logo

TEYI PHARMACEUTICAL GROUP CO.,LTD — Investor Relations & Filings

Ticker · 002728 ISIN · CNE100001WK6 LEI · 300300ZUIZCFPGQWOZ61 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,596 across all filing types
Latest filing 2022-11-15 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 002728

About TEYI PHARMACEUTICAL GROUP CO.,LTD

https://www.tczy.com.cn

TEYI PHARMACEUTICAL GROUP CO.,LTD. specializes in the research, development, manufacturing, and distribution of pharmaceutical products. The company's portfolio primarily consists of Chinese patent medicines and chemical drug preparations. Its flagship product, Zhike Bao Tablets, is widely recognized for treating chronic bronchitis and cough-related ailments. Beyond respiratory health, the group produces a diverse range of medications covering cardiovascular diseases, gastrointestinal disorders, and anti-infective treatments. Teyi Pharmaceutical operates modern production facilities and maintains a robust distribution network to serve healthcare providers and pharmacies. The company emphasizes the integration of traditional medicinal knowledge with modern pharmaceutical technology to enhance product efficacy and safety.

Recent filings

Filing Released Lang Actions
关于提前归还非公开发行暂时补充流动资金的募集资金的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from a company regarding the early repayment of temporarily supplemented working capital from non-publicly issued raised funds. It details the board's approval, the use of idle raised funds for working capital, and the early repayment of these funds. There is no financial statement or detailed financial report included, nor is it a report publication or certification. The content relates to capital structure and financing activities, specifically the use and repayment of raised funds. Therefore, the document fits best under Capital/Financing Update (CAP). The document length is short and focused on a financing update, not a full report or announcement of a report publication.
2022-11-15 Chinese
可转换公司债券交易异常波动公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding abnormal trading fluctuations of convertible bonds issued by the company. It includes details about the bond issuance, trading price deviations, confirmations from company management about no undisclosed material information, and risk warnings to investors. There are no financial statements or detailed financial performance data presented. The document serves as a regulatory disclosure about trading anomalies rather than a financial report or earnings release. It fits the category of a Regulatory Filing (RNS) as it is a compliance-related announcement about trading irregularities and information disclosure obligations.
2022-11-10 Chinese
股票交易异常波动公告
Regulatory Filings Classification · 95% confidence The document is a public announcement regarding abnormal stock price fluctuations for the company 特一药业集团股份有限公司 (stock code 002728). It details the stock price movements over specific dates, confirms the company's operational status, clarifies that no undisclosed material information exists, and references a related shareholding reduction by a major shareholder. The document is short (1278 characters) and serves as a regulatory disclosure about stock trading anomalies rather than a financial report or detailed analysis. It does not contain financial statements, management discussion, or audit information. This type of announcement fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance disclosures that do not fit other categories.
2022-11-09 Chinese
关于持股5%以上股东减持股份超过1%的公告
Major Shareholding Notification Classification · 95% confidence The document is a formal announcement regarding a shareholder (with over 5% ownership) reducing their shareholding by more than 1%. It details the shareholder's identity, the number of shares reduced, the method of reduction (block trade), and confirms no change in control or governance structure. There is no financial statement, earnings data, or management discussion. The document is a notification of a major shareholding change, specifically a reduction in shares held by a significant shareholder. This matches the definition of 'Major Shareholding Notification' (MRQ). The document length is about 3,080 characters, which is consistent with a detailed announcement but not a full report. Therefore, the correct classification is MRQ with high confidence.
2022-11-09 Chinese
监事会决议公告
Regulatory Filings Classification · 95% confidence The document is an announcement of the resolution passed by the Supervisory Board regarding the review of the company's 2022 third quarter report. It states that the Supervisory Board has audited and approved the 2022 Q3 report but does not contain the actual financial statements or substantive financial data itself. The document is short (690 characters) and serves as a formal announcement of the meeting's decision rather than the report itself. Therefore, it fits best as a Regulatory Filing (RNS) since it is a regulatory announcement about the review of a quarterly report, not the report itself.
2022-10-25 Chinese
2022年三季度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled '2022 年第三季度报告' which translates to '2022 Third Quarter Report'. It contains detailed financial data including income statement, balance sheet, cash flow statement, and notes on financial metrics for the third quarter of 2022. The document explicitly states it is a quarterly report and is unaudited. The length of the document (over 11,000 characters) and the presence of comprehensive financial statements confirm it is a substantive financial report for a period shorter than a full fiscal year. Therefore, it fits the definition of an Interim / Quarterly Report (IR). 9M 2022
2022-10-25 Chinese

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.